MENLO PARK, Calif., Dec. 3, 2013 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (Nasdaq:PACB), provider of the PacBio® RS II DNA Sequencing System, today announced it is collaborating with the Wellcome Trust Sanger Institute and Public Health England to complete the sequences of 3,000 bacterial genome strains from PHE's National Collection of Type Cultures (NCTC). Sequencing will be performed at the Sanger Institute. The three-year project could double the number of finished microbial genomes in the GenBank reference database today.
Help employers find you! Check out all the jobs and post your resume.
